Literature DB >> 11283723

Tie receptors: new modulators of angiogenic and lymphangiogenic responses.

N Jones1, K Iljin, D J Dumont, K Alitalo.   

Abstract

Angiogenesis is required for normal embryonic vascular development and aberrant angiogenesis contributes to several diseases, including cancer, diabetes and tissue ischaemia. What are the molecular mechanisms that regulate this important process? The Tie family of receptors and their ligands, the angiopoietins, are beginning to provide insight into how vessels make decisions such as whether to grow or regress--processes that are important not only during development but throughout an organism's life.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11283723     DOI: 10.1038/35067005

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  92 in total

Review 1.  Molecular control of arterial-venous blood vessel identity.

Authors:  Ralf H Adams
Journal:  J Anat       Date:  2003-01       Impact factor: 2.610

2.  Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells.

Authors:  Akiyoshi Uemura; Minetaro Ogawa; Masanori Hirashima; Takashi Fujiwara; Shinji Koyama; Hitoshi Takagi; Yoshihito Honda; Stanley J Wiegand; George D Yancopoulos; Shin-Ichi Nishikawa
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 3.  Cellular and molecular mechanisms of embryonic haemangiogenesis and lymphangiogenesis.

Authors:  Jörg Wilting; Bodo Christ; Li Yuan; Anne Eichmann
Journal:  Naturwissenschaften       Date:  2003-09-17

4.  Molecular profiling of angiogenic markers: a step towards interpretive analysis of a complex biological function.

Authors:  Kevin P Claffey
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

5.  Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis.

Authors:  Clare R Ozawa; Andrea Banfi; Nicole L Glazer; Gavin Thurston; Matthew L Springer; Peggy E Kraft; Donald M McDonald; Helen M Blau
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

Review 6.  Revisiting cardiovascular regeneration with bone marrow-derived angiogenic and vasculogenic cells.

Authors:  Sangho Lee; Young-Sup Yoon
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

7.  Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes.

Authors:  Yanping Ding; Nan Song; Yongzhang Luo
Journal:  Cancer Microenviron       Date:  2012-04-20

8.  Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging.

Authors:  Ketan B Ghaghada; Cristian T Badea; Lohitash Karumbaiah; Nicole Fettig; Ravi V Bellamkonda; G A Johnson; Ananth Annapragada
Journal:  Acad Radiol       Date:  2011-01       Impact factor: 3.173

9.  TGF-β1 promotes lymphangiogenesis during peritoneal fibrosis.

Authors:  Hiroshi Kinashi; Yasuhiko Ito; Masashi Mizuno; Yasuhiro Suzuki; Takeshi Terabayashi; Fumiko Nagura; Ryohei Hattori; Yoshihisa Matsukawa; Tomohiro Mizuno; Yukihiro Noda; Hayato Nishimura; Ryosuke Nishio; Shoichi Maruyama; Enyu Imai; Seiichi Matsuo; Yoshifumi Takei
Journal:  J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 10.121

10.  4-isothiocyanate-2, 2, 6, 6-tetramethyl piperidinooxyl inhibits angiogenesis by suppressing VEGFR2 and Tie2 phosphorylation.

Authors:  Yuanyuan Liu; Jing Gao; Shuangsheng Huang; Lamei Hu; Zhiqiang Wang; Zheyuan Wang; Xiao Chen; Xiaoyu Zhang; Wenguang Li
Journal:  Oncol Lett       Date:  2016-08-03       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.